Three key policy proposals aimed at bolstering generics and biosimilars have been set out by French off-patent industry association Gemme, in response to a lack of measures included in the country’s latest annual PLFSS social security legislation.
Bemoaning the draft legislation’s lack of “any measure likely to significantly loosen the grip of economic pressure weighing on generics...




